Contineum Therapeutics shares owned by Goldman Sachs Group
Quarter-by-quarter ownership of Contineum Therapeutics (CTNM) shares owned by Goldman Sachs Group
from 13F filings
Historical chart of Goldman Sachs Group investment in Contineum Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Contineum Therapeutics held by Goldman Sachs Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Contineum Therapeutics by Goldman Sachs Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $354k | 30k | 11.75 |
| 2025-03-31 | $99k | 14k | 6.98 |
| 2024-12-31 | $386k | 26k | 14.65 |